Intnl. Biotechnology - Appointment of Non-executive Director

International Biotechnology Trust

23/01/2023 17:22

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230123:nRSW6026Na&default-theme=true

RNS Number : 6026N  Intl. Biotechnology Trust PLC  23 January 2023

23 January 2023

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

 

Appointment of Non-executive Director

The Board of the Company is pleased to announce the appointment of Gillian
Elcock as a Non-executive Director of the Company with effect from 1 February
2023.

Gillian Elcock is the founder of Denny Ellison, an independent research and
analyst training company, and was its Managing Director for ten years. Prior
to this, she worked as an equity research analyst for several years at Putnam
Investments and Insight Investment. She was named a finalist in the
'Investment Analyst of the Year' category of the Women in Investment Awards
2018. She started her career as a management consultant at The Boston
Consulting Group.

Gillian is a member of the Board of the CFA UK and was previously Chair of the
society's Networks Steering Committee and a member of its Nominating
Committee. She holds an MBA from the Harvard Business School and MEng and BSc
degrees from the Massachusetts Institute of Technology.

The following additional information is disclosed in accordance with Chapter 9
of the Financial Conduct Authority Listing Rules:

1.   There are no details to be disclosed under Listing Rule 9.6.13.

2.   As at today's date Gillian Elcock has no beneficial interest in the
Ordinary shares of the Company.

 

For further information contact:

 

Broker - Numis

 

Nathan Brown                +44 (0)20 7260 1426 / +44 (0)7795
964 870

 

Vicki Paine                    +44 (0)20 7260 1256 / +44
(0)78 8431 1486

 

 

Company Secretary - Link Company Matters

 

Indu Shastri                   +44 (0)7936 045789

 

 

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAMZGZMNFNGFZM